|
Current Issue
Archive
Supplements
Articles in Press
Journal Information
Aims and Scope
Editorial Office
Editorial Board
Register as Author
Register as Reviewer
Instructions for Authors
Abstracting and indexing
Subscription
Advertising Information
Links
Interview with Professor Janusz Skowronek ABS 2015 |
4/2016
vol. 8 abstract:
Original paper
Modelling the radiobiological effect of intraoperative X-ray brachytherapy for breast cancer using an air-filled spherical applicatorKris Armoogum, Simon Evans, David MorganJ Contemp Brachytherapy 2016; 8, 4: 313–318
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Purpose: We present a framework, in which we compare a conventional standard dose of 50 Gy in 25 fractions with accelerated partial breast irradiation (APBI) using electronic brachytherapy (eBT). We discuss how radiobiological modelling enables us to establish a framework, within which we can compare external beam radiotherapy (EBRT). This leads to a determination of the shell of isoeffect in breast tissue, at which very low kV eBT can be considered to be clinically equivalent to standard EBRT.
Material and methods: To estimate relative biological effectiveness (RBE) values as a function of dose and irradiation time, we used a modified linear quadratic (LQ) approach, taking into account the ability of this new device, to deliver 20 Gy at the surface of a 40 mm diameter rigid, hollow spherical applicator in less than 2 minutes. In this study, we considered the radiobiological effectiveness of the Papillon+™ X-ray brachytherapy device operating at 30 kV, 0.3 mA producing dose rates in excess of 14 Gy/min. Results: Calculated clinical RBEs ranged from 1.154 at the surface of a 40 mm diameter applicator to 1.100 at 35 mm from the applicator surface for the Papillon+ device. The absolute physical dose D (abs) 30 kV ranged from 20.00 Gy at the applicator surface to 1.20 at 35 mm distant. The product of the isoeffective single dose of 60Co reference radiation – (RBE)60Co, and the RBE corrected standard 2 Gy equivalent dose fractions (EQD2) doses, EQD2(30 kV) * (RBE)60Co ranged from 98.62 Gy at the applicator surface to 1.13 at 35 mm. The ‘shell of isoeffect’, the value on the X-axis where the EQD2(30 kV) * (RBE)60Co line crosses the 50 Gy mark on the Y-axis, was found to be approximately 3.5 mm beyond the applicator surface. Conclusions: The ‘shell of isoeffect’ can serve as a useful metric with which to compare the radiobiological effectiveness of low kV eBT with various regimes of conventional EBRT. keywords:
brachytherapy, breast cancer, radiobiology, X-ray |